Looking Back on Dermatology's Historic 2023 with Raj Chovatiya, MD, PhD
2023 was a year of both advancements and setbacks for various treatments, and this discussion covers the most significant moves by the FDA this year.
Eli Lilly Smitht Lawrence Eichenfield Raj Chovatiya Verrica Pharmaceuticals Northwestern University Feinberg School Of Medicine Drug Administration
Source: hcplive.com